Bank Of New York Mellon Corp Editas Medicine, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$7.03 - $11.53 $1.85 Million - $3.04 Million	263,667 New	263,667 $1.91 Billion
Q4 2022 Feb 14, 2023	BUY	$8.32 - $13.21 $2.14 Million - $3.39 Million	256,785 New	256,785 $2.28 Million
Q3 2022 Nov 14, 2022	BUY	$12.16 - $19.42 $247,176 - $394,750	20,327 Added 8.73%	253,291 $3.1 Million
Q2 2022 Aug 15, 2022	SELL	$9.99 - $21.35 $558,580 - $1.19 Million	-55,914 Reduced 19.36%	232,964 $2.76 Million
Q1 2022 May 11, 2022	BUY	$14.08 - $27.63 $14,924 - $29,287	1,060 Added 0.37%	288,878 $5.49 Million
Q4 2021 Feb 11, 2022	SELL	$26.55 - $40.57 $362,221 - $553,496	-13,643 Reduced 4.53%	287,818 $7.64 Million
Q3 2021 Nov 12, 2021	BUY	$39.27 - $72.94 $1.11 Million - $2.06 Million	28,207 Added 10.32%	301,461 $12.4 Million
Q2 2021 Aug 11, 2021	BUY	$31.29 - $56.64 $601,143 - $1.09 Million	19,212 Added 7.56%	273,254 $15.5 Million
Q1 2021 May 13, 2021	SELL	$39.71 - $90.58 $1.03 Million - $2.35 Million	-25,952 Reduced 9.27%	254,042 $10.7 Million
Q4 2020 Feb 09, 2021	BUY	$27.07 - $84.35 $817,920 - $2.55 Million	30,215 Added 12.1%	279,994 $19.6 Million
Q3 2020 Nov 12, 2020	SELL	$28.06 - $37.16 $1.87 Million - $2.47 Million	-66,582 Reduced 21.05%	249,779 $7.01 Million
Q2 2020 Aug 12, 2020	BUY	$18.5 - $34.34 $1.12 Million - $2.07 Million	60,383 Added 23.59%	316,361 $9.36 Million
Q1 2020 May 06, 2020	SELL	$14.88 - $32.78 $57,526 - $126,727	-3,866 Reduced 1.49%	255,978 $5.08 Million
Q4 2019 Feb 14, 2020	BUY	$19.49 - $32.63 $184,394 - $308,712	9,461 Added 3.78%	259,844 $7.69 Million
Q3 2019 Nov 07, 2019	BUY	$22.49 - $26.81 $957,624 - $1.14 Million	42,580 Added 20.49%	250,383 $5.69 Million
Q2 2019 Aug 12, 2019	SELL	$20.48 - $27.76 $251,985 - $341,559	-12,304 Reduced 5.59%	207,803 $5.14 Million
Q1 2019 May 14, 2019	BUY	$19.43 - $26.41 $380,925 - $517,768	19,605 Added 9.78%	220,107 $5.38 Million
Q4 2018 Feb 11, 2019	BUY	$18.19 - $31.79 $30,031 - $52,485	1,651 Added 0.83%	200,502 $4.56 Million
Q3 2018 Nov 09, 2018	BUY	$27.65 - $38.39 $154,259 - $214,177	5,579 Added 2.89%	198,851 $0
Q2 2018 Aug 06, 2018	SELL	$31.4 - $41.01 $335,446 - $438,109	-10,683 Reduced 5.24%	193,272 $6.93 Million
Q1 2018 May 15, 2018	BUY	$29.84 - $44.08 $1.33 Million - $1.97 Million	44,654 Added 28.03%	203,955 $6.76 Million
Q4 2017 Feb 09, 2018	BUY	$21.89 - $31.34 $3.49 Million - $4.99 Million	159,301	159,301 $4.9 Million

Others Institutions Holding EDIT

# of Institutions

244

Shares Held

56.8M

Call Options Held

410K

Put Options Held

394K

Black Rock Inc. New York, NY

7.78M
Shares

$10.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$8.75 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.9M
Shares

$6.42 Million
0.62% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.35M
Shares

$4.39 Million
0.01% of portfolio
State Street Corp Boston, MA

2.46M
Shares

$3.23 Million
0.0% of portfolio

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account